Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous BM-MNC + BM-MSC for Chronic Critical Limb Ischemia
NCT01456819Phase 2Unknown
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Mar 2011
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in critical limb ischemia (CLI), sponsored by Universiti Kebangsaan Malaysia. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01456819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01456819.